Studies a device that removes blood clots from brain arteries in stroke
Tests the Tigertriever device to remove clots in adults with stroke within 8 hours.
Plain-language title generated from the registry record
Registry title: Michigan Initial Experience Using Tigertriever for Thrombectomy
Key facts
- Where
- Detroit, United StatesSee the site
Where in United States
- Henry Ford HospitalDetroit, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Henry Ford Health System
- Trial code
- NCT07363525
- Record updated
- 8 May 2026
- Original description
The purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of the Tigertriever in restoring blood flow by removing thrombus (or blood clot) from a large intracranial vessel (blood vessel in the brain) in patients experiencing ischemic stroke within 8 hours of symptom onset.Read full original descriptionShow less
Michigan Initial Experience Using Tigertriever for Thrombectomy
The purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of the Tigertriever in restoring blood flow by removing thrombus (or blood clot) from a large intracranial vessel (blood vessel in the brain) in patients experiencing ischemic stroke within 8 hours of symptom onset.
Inclusion: Patients admitted with large vessel occlusion (LVO) and treated with the Tigertriever, as per the approved indication; Tigertriever was used as the first line treatment in the target vessel; A signed informed consent; Age ≥ 18.
Exclusion: -1. Evidence of acute brain hemorrhage on NCCT or MR at admission. 2. Prior hemorrhage, stroke, thrombolysis, and/or endovascular therapy in the last 3 months; pre-stroke disability (pre-stroke mRS ≥ 2).